Idex Corporation (IEX)

$201.68

+3.38

(+1.7%)▲

Market is closed - opens 8 PM, 01 Dec 2023

Insights on Idex Corporation

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 846.2M → 793.4M (in $), with an average decrease of 6.2% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, 138.6M → 209.1M (in $), with an average increase of 33.7% per quarter

  • Vs PH

    In the last 1 year, Parker-hannifin Corporation has given 43.2% return, outperforming this stock by 59.7%

  • Vs ETN

    In the last 3 years, Eaton Corporation Plc has given 60.2% return, outperforming this stock by 57.5%

Performance

  • $197.32
    $201.75
    $201.68
    downward going graph

    2.16%

    Downside

    Day's Volatility :2.19%

    Upside

    0.03%

    downward going graph
  • $183.77
    $243.37
    $201.68
    downward going graph

    8.88%

    Downside

    52 Weeks Volatility :24.49%

    Upside

    17.13%

    downward going graph

Returns

PeriodIdex CorporationSector (Industrials)S&P500
3 Months
-13.3%
-2.6%
0.8%
6 Months
-2.21%
7.8%
8.2%
1 Year
-16.5%
4.1%
11.5%
3 Years
2.67%
20.3%
25.7%

Highlights

Market Capitalization
15.1B
Book Value
$44.79
Dividend Share
2.52
Dividend Yield
1.29%
Earnings Per Share (EPS)
8.13
PE Ratio
24.5
PEG Ratio
2.15
Wall Street Target Price
220.42
Profit Margin
18.74%
Operating Margin TTM
23.57%
Return On Assets TTM
9.19%
Return On Equity TTM
19.95%
Revenue TTM
3.3B
Revenue Per Share TTM
43.62
Quarterly Revenue Growth YOY
-3.6999999999999997%
Gross Profit TTM
1.4B
EBITDA
922.1M
Diluted Eps TTM
8.13
Quarterly Earnings Growth YOY
0.17
EPS Estimate Current Year
8.15
EPS Estimate Next Year
8.45
EPS Estimate Current Quarter
1.89
EPS Estimate Next Quarter
1.82

Analyst Recommendation

Buy
    64%Buy
    35%Hold
    0
    0%Sell
Based on 17 Wall street analysts offering stock ratings for Idex Corporation(by analysts ranked 0 to 5 stars)
Based on 17 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
6
6
7
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 9.29%

Current $201.68
Target $220.42

Company Financials

FY17Y/Y Change
Revenue
2.3B
↑ 8.25%
Net Income
337.3M
↑ 24.4%
Net Profit Margin
14.74%
↑ 1.91%
FY18Y/Y Change
Revenue
2.5B
↑ 8.58%
Net Income
410.6M
↑ 21.74%
Net Profit Margin
16.53%
↑ 1.79%
FY19Y/Y Change
Revenue
2.5B
↑ 0.44%
Net Income
425.5M
↑ 3.64%
Net Profit Margin
17.06%
↑ 0.53%
FY20Y/Y Change
Revenue
2.4B
↓ 5.73%
Net Income
377.8M
↓ 11.22%
Net Profit Margin
16.06%
↓ 1.0%
FY21Y/Y Change
Revenue
2.8B
↑ 17.57%
Net Income
449.4M
↑ 18.96%
Net Profit Margin
16.25%
↑ 0.19%
FY22Y/Y Change
Revenue
3.2B
↑ 15.09%
Net Income
586.9M
↑ 30.6%
Net Profit Margin
18.44%
↑ 2.19%
Q2 FY22Q/Q Change
Revenue
796.1M
↑ 5.99%
Net Income
138.2M
↓ 1.29%
Net Profit Margin
17.36%
↓ 1.28%
Q3 FY22Q/Q Change
Revenue
824.0M
↑ 3.5%
Net Income
178.7M
↑ 29.31%
Net Profit Margin
21.69%
↑ 4.33%
Q4 FY22Q/Q Change
Revenue
810.7M
↓ 1.61%
Net Income
130.0M
↓ 27.25%
Net Profit Margin
16.04%
↓ 5.65%
Q1 FY23Q/Q Change
Revenue
845.4M
↑ 4.28%
Net Income
139.8M
↑ 7.54%
Net Profit Margin
16.54%
↑ 0.5%
Q2 FY23Q/Q Change
Revenue
846.2M
↑ 0.09%
Net Income
138.6M
↓ 0.86%
Net Profit Margin
16.38%
↓ 0.16%
Q3 FY23Q/Q Change
Revenue
793.4M
↓ 6.24%
Net Income
209.1M
↑ 50.87%
Net Profit Margin
26.35%
↑ 9.97%
FY17Y/Y Change
Total Assets
3.4B
↑ 7.76%
Total Liabilities
1.5B
↓ 6.08%
FY18Y/Y Change
Total Assets
3.5B
↑ 2.09%
Total Liabilities
1.5B
↓ 2.34%
FY19Y/Y Change
Total Assets
3.8B
↑ 9.89%
Total Liabilities
1.6B
↑ 4.94%
FY20Y/Y Change
Total Assets
4.4B
↑ 15.74%
Total Liabilities
1.9B
↑ 20.85%
FY21Y/Y Change
Total Assets
4.9B
↑ 11.39%
Total Liabilities
2.1B
↑ 12.81%
FY22Y/Y Change
Total Assets
5.5B
↑ 12.09%
Total Liabilities
2.5B
↑ 16.94%
Q2 FY22Q/Q Change
Total Assets
4.9B
↓ 1.74%
Total Liabilities
2.1B
↑ 1.14%
Q3 FY22Q/Q Change
Total Assets
4.9B
↓ 0.41%
Total Liabilities
2.1B
↓ 1.64%
Q4 FY22Q/Q Change
Total Assets
5.5B
↑ 12.66%
Total Liabilities
2.5B
↑ 18.29%
Q1 FY23Q/Q Change
Total Assets
5.7B
↑ 2.65%
Total Liabilities
2.4B
↓ 1.77%
Q2 FY23Q/Q Change
Total Assets
5.7B
↑ 1.09%
Total Liabilities
2.4B
↑ 0.51%
Q3 FY23Q/Q Change
Total Assets
5.7B
↓ 0.88%
Total Liabilities
2.3B
↓ 6.5%
FY17Y/Y Change
Operating Cash Flow
432.8M
↑ 8.21%
Investing Cash Flow
-54.7M
↓ 89.25%
Financing Cash Flow
-277.4M
↓ 695.99%
FY18Y/Y Change
Operating Cash Flow
479.3M
↑ 10.77%
Investing Cash Flow
-81.4M
↑ 48.74%
Financing Cash Flow
-290.0M
↑ 4.54%
FY19Y/Y Change
Operating Cash Flow
528.1M
↑ 10.16%
Investing Cash Flow
-137.0M
↑ 68.26%
Financing Cash Flow
-227.6M
↓ 21.53%
FY20Y/Y Change
Operating Cash Flow
569.3M
↑ 7.8%
Investing Cash Flow
-172.6M
↑ 25.95%
Financing Cash Flow
-42.6M
↓ 81.28%
FY21Y/Y Change
Operating Cash Flow
565.3M
↓ 0.7%
Investing Cash Flow
-698.1M
↑ 304.52%
Financing Cash Flow
-9.5M
↓ 77.7%
FY22Y/Y Change
Operating Cash Flow
557.4M
↓ 1.4%
Investing Cash Flow
-917.2M
↑ 31.39%
Financing Cash Flow
-38.3M
↑ 303.16%
Q2 FY22Q/Q Change
Operating Cash Flow
112.3M
↑ 40.9%
Investing Cash Flow
-135.7M
↑ 9.08%
Financing Cash Flow
-125.8M
↑ 76.44%
Q3 FY22Q/Q Change
Operating Cash Flow
198.1M
↑ 76.4%
Investing Cash Flow
-224.4M
↑ 65.36%
Financing Cash Flow
-77.5M
↓ 38.39%
Q4 FY22Q/Q Change
Operating Cash Flow
167.3M
↓ 15.55%
Investing Cash Flow
-917.2M
↑ 308.73%
Financing Cash Flow
236.3M
↓ 404.9%
Q1 FY23Q/Q Change
Operating Cash Flow
147.9M
↓ 11.6%
Investing Cash Flow
-29.2M
↓ 96.82%
Financing Cash Flow
-45.2M
↓ 119.13%
Q2 FY23Q/Q Change
Operating Cash Flow
141.2M
↓ 4.53%
Investing Cash Flow
-147.4M
↑ 404.79%
Financing Cash Flow
-46.8M
↑ 3.54%
Q3 FY23Q/Q Change
Operating Cash Flow
226.6M
↑ 60.48%
Investing Cash Flow
-90.0M
↓ 38.94%
Financing Cash Flow
-194.7M
↑ 316.03%

Technicals Summary

Sell

Neutral

Buy

Idex Corporation is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Idex Corporation
Idex Corporation
4.08%
-2.21%
-16.5%
2.67%
44.32%
Emerson Electric Co.
Emerson Electric Co.
-0.16%
12.65%
-7.79%
14.96%
30.79%
Illinois Tool Works Inc.
Illinois Tool Works Inc.
7.72%
7.55%
5.87%
14.09%
73.2%
Parker-hannifin Corporation
Parker-hannifin Corporation
15.83%
29.62%
43.19%
60.17%
148.81%
General Electric Company
General Electric Company
8.24%
16.07%
38.26%
45.95%
90.48%
Eaton Corporation Plc
Eaton Corporation Plc
14.17%
24.2%
38.15%
86.44%
193.48%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Idex Corporation
Idex Corporation
24.5
24.5
2.15
8.15
0.2
0.09
0.01
44.79
Emerson Electric Co.
Emerson Electric Co.
23.79
23.79
2.3
4.46
0.1
0.05
0.02
36.17
Illinois Tool Works Inc.
Illinois Tool Works Inc.
23.48
23.48
2.3
9.75
1.05
0.17
0.02
9.98
Parker-hannifin Corporation
Parker-hannifin Corporation
24.04
24.04
1.69
20.91
0.24
0.08
0.01
82.24
General Electric Company
General Electric Company
12.48
12.48
0.74
2.67
0.35
0.03
0.0
26.34
Eaton Corporation Plc
Eaton Corporation Plc
30.58
30.58
2.11
9.03
0.17
0.06
0.02
46.04
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Idex Corporation
Idex Corporation
Buy
$15.1B
44.32%
24.5
18.74%
Emerson Electric Co.
Emerson Electric Co.
Buy
$50.5B
30.79%
23.79
87.17%
Illinois Tool Works Inc.
Illinois Tool Works Inc.
Hold
$72.8B
73.2%
23.48
19.55%
Parker-hannifin Corporation
Parker-hannifin Corporation
Buy
$55.7B
148.81%
24.04
11.92%
General Electric Company
General Electric Company
Buy
$130.6B
90.48%
12.48
11.9%
Eaton Corporation Plc
Eaton Corporation Plc
Buy
$91.3B
193.48%
30.58
13.24%

Institutional Holdings

  • Vanguard Group Inc

    12.16%

  • T. Rowe Price Associates, Inc.

    8.70%

  • BlackRock Inc

    7.88%

  • State Street Corporation

    3.90%

  • Morgan Stanley - Brokerage Accounts

    3.06%

  • Wellington Management Company LLP

    2.95%

Corporate Announcements

  • Idex Corporation Dividends March,2024

    In the quarter ending March,2024. Idex Corporation has declared dividend of $0.64

    Read More

Company Information

idex (nyse: iex) is a company that has undoubtedly touched your life in some way. in fact, idex businesses make thousands of products that are mission-critical components in everyday activities. chances are the car you’re driving has a band-it® clamp holding your side airbag safely in place. if you were ever in a car accident, a hurst jaws of life® rescue tool may have saved your life. if you or a family member is battling cancer, your doctor may have tested your dna in a quest to find the best targeted medicine for you. it’s likely your dna test was run on equipment that contains components made by our growing idex health & science team.

Organization
Idex Corporation
Employees
8500
CEO
Mr. Eric D. Ashleman
Industry
Producer Manufacturing

Discover More

FAQs